NCT00390104Recruiting
Molecular Analysis of Patients With Neuromuscular Disease
Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members
Source: ClinicalTrials.gov · Last updated 24 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 17 Oct 2006
- Start date
- Jan 2002
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Boston Children's Hospital
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT00390104
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Jan 2002 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- not having a neuromuscular diagnosis in you or a family member
- not wishing to participate
- being incapable of giving consent and not having a legal guardian willing or able to do so
Who the study is looking for
- having a clinical and/or pathological diagnosis of a muscular dystrophy
- being the first degree relative of someone with such a diagnosis
- having had a muscle biopsy if diagnosed with a neuromuscular disease
- willingness to provide a skin biopsy for research only
Criteria the registry did not label
- The samples used in this study will be derived from individuals at risk for, or suffering from, neuromuscular disease, generally resulting in clinical weakness of one or more muscle groups and their family members.
Age in the registry: 1 week to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boston Children's Hospital Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.